Cure My Disease

Don't miss your cure!

 Log in / Sign up

Back brace showdown: can two posture correctors boost mobility in older adults?

NCT ID NCT06970470

Symptom relief Sponsor: Pontificia Universidade Católica do Rio Grande do Sul Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 08, 2026 · Last updated Oct 09, 2026 · Updated 1 time

Summary

Researchers are testing whether two different thoracic back braces improve walking, muscle strength, and daily activity in older adults with hyperkyphosis, an excessive forward curve of the upper spine. About 100 participants aged 60 and older who walk independently and attend a supervised exercise program join the study. They are randomly assigned to one of four groups: a triple-adjustable posture corrector, a dynamic elastic-resistance brace, a placebo brace that looks similar but does not correct posture, or no brace. Everyone continues their exercise program, and those wearing braces follow a 16-week schedule that builds up to four hours a day. Researchers measure walking speed, trunk and shoulder muscle torque, and physical activity before and after the 16 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Two types of thoracic back braces (posture correctors) and a placebo brace
What this could lead to
If the braces help, clinicians could have clearer guidance on whether a back brace supports walking and strength in older adults with hyperkyphosis.
What could go wrong
The trial is small and early, and braces may not change walking or muscle strength beyond what exercise alone provides. Wearing a brace for hours a day can be uncomfortable, and some participants may not stick with it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 60 years or older * Thoracic hyperkyphosis with Cobb angle of 40 degrees or more (Goniometer-Pro app) * Ability to walk independently without assistive devices * Active participation in a supervised physical activity program (Senior Physical Activity Incentive Program - PIAFI, PUCRS) Exclusion Criteria: * Cognitive impairment, defined by Mini-Mental State Examination scores below education-adjusted cutoffs * Inability to complete the required assessments (gait analysis, isokinetic dynamometry, accelerometry) * Non-compliance with orthosis use during the intervention period * Discontinuation of participation in the PIAFI supervised exercise program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hyperkyphosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Kyphosis Scheuermann disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hyperkyphosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Pontifical Catholic University of Rio Grande do Sul

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90619-900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.